A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...

With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...

The NK cells first are activated with cytokines ... and vice president and head of MD Anderson’s Institute for Cell Therapy Discovery & Innovation. Through the institute, Rezvani and her ...

When your body senses something is wrong—whether it's a damaged cell or a growing tumor—it can react in many ways. One of the ...

Senti Biosciences, Inc.’s SNTI share price has surged by 6.40%, which has investors questioning if this is right time to sell ...

Drug discovery efforts have expanded beyond the traditional approaches of small molecules and antibodies to include cells.

Artiva Biotherapeutics, Inc.’s ARTV share price has dipped by 5.22%, which has investors questioning if this is right time to buy.

Natural killer (NK) cells are pivotal in the innate immune response against cancer and viral infections, with their presence in tumors correlating to better patient outcomes in various cancers.

Converging computational and laboratory technologies are helping anti-cancer immune responses hit their target more ...

Taconic Biosciences prioritizes accessibility and efficiency in preclinical research. Unlike other providers, Taconic does not charge access fees for the use of NOG mice, which can otherwise range ...

Collaboration partner, Gilead Sciences, to begin Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy volunteers in Q2 2025 ...